TIL compared with OM: revenue, margins and what each company keeps, and the suppliers and customers both name

TILInstil Bio, Inc.

Mkt capRevenueRevenue

OMOutset Medical, Inc.

Mkt capRevenueRevenue

Compare

TILInstil Bio, Inc.

OMOutset Medical, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

TIL: latest quarter not drawable. OM: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TIL 2

AZNAstraZeneca Pharmaceuticalscustomer

—ImmuneOnco Biopharmaceuticals (Shanghai)unlistedsupplier

Shared 0

No shared counterparties.

Only OM 1

—Tacnaunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

TIL, solidOM, dashed

TILInstil Bio, Inc.

6.58▼−3.24%· post 6.58· delayed

Mkt cap$46.1MRevenue—Revenue—

OMOutset Medical, Inc.

4.01▼−0.50%· post 4.01· delayed

After hoursNov 2 '26delayed

Mkt cap$75.6MRevenue$32MQ2 FY26Revenue$119MFY25

Compare

After hoursNov 2 '26delayed

TILInstil Bio, Inc.

OMOutset Medical, Inc.

6.58▼−3.24%post 6.58delayed

Price

4.01▼−0.50%post 4.01delayed

$46.1M

Mkt cap

$75.6M

—

Revenue

$32MQ2 FY26

—

Revenue

$119MFY25

TIL6.58▼−3.24%vsOM4.01▼−0.50%After hoursNov 2 '26delayed